Clinical Trial Update: Study of Ezatiostat (Telintra Tablets) for Treatment of Severe Chronic Neutropenia [Phase 2]

View source ↗

Summary

Phase 2 trial of ezatiostat (Telintra) for severe chronic neutropenia has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neutropenia

Drugs mentioned

• Telintra

Snippet

Sponsor: Telik | Conditions: Severe Chronic Neutropenia | Phase 2 | Status: TERMINATED